Diabetic dyslipidemia: a practical guide to therapy

Low-density lipoprotein (LDL) should be the primary target of lipid-lowering therapy for patients with diabetes. Because of their robust reduction of LDL, statins are considered the agents of choice for these patients. Triglyceride (TG) and high-density lipoprotein (HDL) levels are also important ta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of family practice 2008-06, Vol.57 (6), p.377-388
Hauptverfasser:	Tovar, John M, Bazaldua, Oralia V, Loffredo, Alexandra
Format:	Artikel
Sprache:	eng
Schlagworte:	Clofibric Acid - therapeutic use Coronary Disease - prevention & control Diabetes Complications - complications Drug Therapy, Combination Dyslipidemias - drug therapy Dyslipidemias - etiology Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Lipoproteins, HDL - blood Lipoproteins, LDL - blood Niacin - therapeutic use Practice Guidelines as Topic Primary Prevention Treatment Outcome Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Low-density lipoprotein (LDL) should be the primary target of lipid-lowering therapy for patients with diabetes. Because of their robust reduction of LDL, statins are considered the agents of choice for these patients. Triglyceride (TG) and high-density lipoprotein (HDL) levels are also important targets. Combination therapy with fibrates or niacin is common due to concurrent high TG and low HDL levels in these patients. Data supporting an LDL goal of
ISSN:	1533-7294